-

Jefferson Health and MDClone Partner to Build Healthcare System of the Future

Using MDClone, Jefferson Health will leverage synthetic data for collaborative efforts around the world to enable real-time clinical exploration

BE’ER SHEVA, Israel & PHILADELPHIA--(BUSINESS WIRE)--MDClone and Thomas Jefferson University/Jefferson Health are excited to announce a new partnership to help drive innovation in healthcare. As part of a newly signed license arrangement, MDClone and Jefferson Health will work together to deploy technology and insights to unlock healthcare data to enable more research and more solutions that promote quality, safety, and efficiency in healthcare.

“We are thrilled to begin working with Jefferson Health,” said Ziv Ofek, Founder and CEO. “We have a unique opportunity to foster collaboration around the world by giving physicians and researchers tools that enable real-time clinical exploration. The power of leveraging data for better healthcare delivery is truly a global desire and this collaboration is an example where Jefferson Health and other MDClone customers can make a direct impact. Starting with this agreement with an innovative powerhouse like Jefferson Health, we are eager to connect to other like-minded health systems and will be sharing more details on ways to grow this partnership to include other institutions.”

MDClone’s platform democratizes data across the healthcare ecosystem, making it easier for healthcare professionals and researchers to identify and leverage actionable information that can transform patient care and outcomes. The differentiating features of MDClone’s technology lie in its flexible yet powerful infrastructure that enables collaboration. By combining longitudinal data organization with a synthetic data engine, organizations can quickly identify and explore useful data and securely collaborate on discovery and insight exploration with others around the world.

"I believe our collaboration with MDClone and Sheba Medical Center in Israel will give us the tools to build the system of the future - focused on prevention and keeping people healthy," said Stephen K. Klasko, MD, president of Thomas Jefferson University and CEO of Jefferson Health. "For decades, we have sought to integrate large population health datasets with the care of an individual patient. MDClone allows us to do exactly that with a clear dashboard for any clinician."

“This innovative partnership with MDClone further cements Thomas Jefferson University’s growing collaboration with forward-thinking partners in Israel,” said Mark L. Tykocinski, MD, provost of Thomas Jefferson University and dean of its Sidney Kimmel Medical College. “Through the Jefferson Israel Center—which was established in Jerusalem in 2018 to foster global education, health care and innovation initiatives—Jefferson and the Israel Innovation Authority recently announced $1 million in awards to start-up companies there. This Spring, students from Thomas Jefferson University’s architecture and industrial design programs teamed up with Sheba Medical Center to present ideas for that system’s visionary ‘City of Health’ initiative, the first phase of an exciting partnership which will carry on into the future. With this ever-increasing level of collaboration, Jefferson’s relationship with Israeli healthcare partners will only grow stronger. This partnership with MDClone builds upon that blossoming relationship.”

About Jefferson Health
Jefferson Health is reimagining healthcare in the greater Philadelphia region and southern New Jersey. Jefferson's dedicated team of doctors, nurses, health professionals and staff provides a range of primary to highly-specialized care through 14 hospitals (seven are Magnet®-designated by the ANCC for nursing excellence), more than 40 outpatient and urgent care locations, the NCI-designated Sidney Kimmel Cancer Center, Magee Rehabilitation and the JeffConnect® telemedicine program. For 2019-2020, Thomas Jefferson University Hospitals is ranked among the nation's best hospitals in eight specialties by U.S. News & World Report. Jefferson Health's mission is to improve the lives of patients in the communities it is privileged to serve through safe, effective, equitable, compassionate care.

About MDClone
MDClone democratizes data, empowering exploration, discovery and collaboration to improve patients’ health. With MDClone, any user can ask and answer any question in real time. This dramatic paradigm shift is made possible by MDClone’s unique technology for organizing, accessing and protecting the privacy of patient data, enabling healthcare knowledge workers to transform ideas into actionable insights in rapid cycles. Founded in 2016 in Israel, MDClone works with major health systems, payers and life science companies in the U.S., Canada and Israel.

Contacts

Erin Giegling
Director of Strategic Marketing
Erin.giegling@mdclone.com

MDClone


Release Versions

Contacts

Erin Giegling
Director of Strategic Marketing
Erin.giegling@mdclone.com

More News From MDClone

MDClone Launches the Only Synthetic Data Platform for Life Science RWE Project Collaboration

BE'ER SHEVA, Israel--(BUSINESS WIRE)--MDClone, a digital health company and the leader in synthetic data, today announced the launch of The MDClone Connect Platform, an innovative workspace enabling cross-organizational collaboration with dynamic access to 50+ million synthetic patient records. Uniting life sciences, tech companies, and other third-party organizations with leading health systems worldwide, the Connect Platform will allow users to securely and efficiently work together on projec...

MDClone Wins Second Consecutive “Best Healthcare Big Data Platform” Award in Annual MedTech Breakthrough Awards Program

BE’ER SHEVA, Israel--(BUSINESS WIRE)--MDClone, a leading data analytics and synthetic data company, today announced that for the second year in a row, the MDClone ADAMS Platform has been recognized as the “Best Healthcare Big Data Platform” in the annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies, and products in the global health and medical technology market. At the core...

MDClone Raises $63 Million in Series C Funding to Fuel Global Growth

BE’ER SHEVA, Israel--(BUSINESS WIRE)--MDClone, a digital health company, today announced a $63 million Series C round of funding, led by two new investors Warburg Pincus, a leading global growth investor, and Viola Growth, Israel’s leading growth fund, with participation from existing investors aMoon, LightSpeed Venture Partners, and OrbiMed. MDClone provides clinicians and healthcare professionals with the ability to explore healthcare data independently and without barriers. The MDClone ADAMS...
Back to Newsroom